ИСТИНА	Войти в систему Регистрация
	Интеллектуальная Система Тематического Исследования НАукометрических данных
	Главная Поиск Статистика О проекте Помощь

---

Lancet Oncologyжурнал

Статьи, опубликованные в журнале

• • 2022 Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
  • Kelley, Robin Kate, Rimassa, Lorenza, Cheng, Ann-Lii, Kaseb, Ahmed, Qin, Shukui, Zhu, Andrew X., Chan, Stephen L., Melkadze, Tamar, Sukeepaisarnjaroen, Wattana, Breder, Valery, Verset, Gontran, Gane, Edward, Borbath, Ivan, Rangel, Jose David Gomez, Ryoo, Baek-Yeol, Makharadze, Tamta, Merle, Philippe, Benzaghou, Fawzi, Banerjee, Kamalika, Hazra, Saswati, Fawcett, Jonathan, Yau, Thomas
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 23, № 8, с. 995-1008 DOI
• • 2022 Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study
  • Merseburger Axel S., Attard Gerhardt, Åström Lennart, Matveev Vsevolod B., Bracarda Sergio, Esen Adil, Feyerabend Susan, Senkus Elżbieta, Piqueras Marta López-Brea, Boysen Gunther, Gourgioti Georgia, Martins Karla, Chowdhury Simon
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 23, № 11, с. 1398-1408 DOI
• • 2022 The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  • Alvarez E., Force L., Xu R., Compton K., Lu D., Henrikson H., Kocarnik J., Harvey J., Pennini A., Dean F., Fu W., Vargas M., Teegan, Ariffin H., Barr Ronald D., Erdomaeva Y., Gunasekera D., John-Akinola Y., Ketterl T., Kutluk T., Malogolowkin M., Mathur P., Radhakrishnan V., Ries L.Gloeckler, Rodriguez-Galindo C., Sagoyan G., et al.
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 23, № 1, с. 27-52 DOI
• • 2021 Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
  • Goldman Jonathan W., Dvorkin Mikhail, Chen Yuanbin, Reinmuth Niels, Hotta Katsuyuki, Trukhin Dmytro, Statsenko Galina, Hochmair Maximilian J., Özgüroğlu Mustafa, Ji Jun Ho, Garassino Marina Chiara, Voitko Oleksandr, Poltoratskiy Artem, Ponce Santiago, Verderame Francesco, Havel Libor, Bondarenko Igor, Każarnowicz Andrzej, Losonczy György, Conev Nikolay V., Armstrong Jon, Byrne Natalie, Thiyagarajah Piruntha, Jiang Haiyi, Paz-Ares Luis, Trukhin Dmytro, Voitko Nataliia, Poltoratskiy Artem, Chen Yuanbin, Kazarnowicz Andrzej, Paz-Ares Luis, Özgüroglu Mustafa, Conev Nikolay, Hochmair Maximilian, Burghuber Otto, Havel Libor, Çiçin Irfan, Losonczy György, Moiseenko Vladimir, Erman Mustafa, Kowalski Dariusz, Wojtukiewicz Marek, Adamchuk Hryhoriy, Vasilyev Alexander, Shevnia Serhii, Valev Spartak, Reinmuth Niels, Ji Jun Ho, Insa Molla Maria Amelia, Ursol Grygorii, Chiang Anne, Hartl Sylvia, Horváth Zsolt, Pajkos Gábor, Verderame Francesco, Hotta Katsuyuki, Kim Sang-We, Smolin Alexey, Göksel Tuncay, Dakhil Shaker, Roubec Jaromir, Bogos Krisztina, Garassino Marina Chiara, Cornelissen Robin, Lee Jong-Seok, Garcia Campelo Maria Rosario, Lopez Brea Marta, Alacacioglu Ahmet, Casarini Ignacio, Ilieva Rumyana, Tonev Ivan, Somfay Attila, Bar Jair, Zer Kuch Alona, Minelli Mauro, Bartolucci Roberta, Roila Fausto, Saito Haruhiro, Azuma Koichi, Lee Gyeong-Won, Luft Alexander, Urda Michal, Delgado Mingorance Juan Ignacio, Majem Tarruella Margarita, Spigel David, Koynov Krassimir, Zemanova Milada, Panse Jens, Schulz Christian, Pápai Székely Zsolt, Sárosi Veronika, Delmonte Angelo, Bettini Anna Cecilia, Nishio Makoto, Okamoto Isamu, Hendriks Lizza, Mandziuk Slawomir, Lee Yun Gyoo, Vladimirova Lyubov, Isla Casado Dolores, Domine Gomez Manuel, Navarro Mendivil Alejandro, Morán Bueno Teresa, Wu Shang-Yin, Knoble Jeanna, Skrickova Jana, Venkova Violetka, Hilgers Werner, Laack Eckart, Bischoff Helge, Fülöp Andrea, Laczó Ibolya, Kósa Judit, Telekes András, Yoshida Tatsuya, Kanda Shintaro, Hida Toyoaki, Hayashi Hidetoshi, Maeda Tadashi, Kawamura Tetsuji, Nakahara Yasuharu, Claessens Niels, Lee Ki Hyeong, Chiu Chao-Hua, Lin Sheng-Hao, Li Chien-Te, Demirkazik Ahmet, Schaefer Eric, Nikolinakos Petros, Schneider Jeffrey, Babu Sunil, Lamprecht Bernd, Studnicka Michael, Fausto Nino Gorini Carlos, Kultan Juraj, Kolek Vitezslav, Souquet Pierre-Jean, Moro-Sibilot Denis, Gottfried Maya, Smit Egbert, Lee Kyung Hee, Kasan Peter, Chovanec Jozef, Goloborodko Olexandr, Kolesnik Oleksii, Ostapenko Yuriy, Lakhanpal Shailendra, Haque Basir, Chua Winston, Stilwill Joseph, Sena Susana Noemi, Girotto Gustavo Colagiovanni, De Marchi Pedro Rafael Martins, Martinelli de Oliveira Fabricio Augusto, Dos Reis Pedro, Krasteva Rositsa, Zhao Yanqiu, Chen Chengshui, Koubkova Leona, Robinet Gilles, Chouaid Christos, Grohe Christian, Alt Jürgen, Csánky Eszter, Somogyiné Ezer Éva, Heching Norman Isaac, Kim Young Hak, Aatagi Shinji, Kuyama Shoichi, Harada Daijiro, Nogami Naoyuki, Nokihara Hiroshi, Goto Hisatsugu, Staal van den Brekel Agnes, Cho Eun Kyung, Kim Joo-Hang, Ganea Doina, Ciuleanu Tudor, Popova Ekaterina, Sakaeva Dina, Stresko Marian, Demo Pavol, Godal Robert, Wei Yu-Feng, Chen Yen-Hsun, Hsia Te-Chun, Lee Kang-Yun, Chang Huang-Chih, Wang Chin-Chou, Dowlati Afshin, Sumey Christopher, Powell Steven, Goldman Jonathan, Zarba Juan Jose, Batagelj Emilio, Pastor Andrea Viviana, Zukin Mauro, Baldotto Clarissa Serodio da Rocha, Schlittler Luis Alberto, Calabrich Aknar, Sette Claudia, Dudov Asen, Zhou Caicun, Lena Hervé, Lang Susanne, Pápai Zsuzsanna, Goto Koichi, Umemura Shigeki, Kanazawa Kenya, Hara Yu, Shinoda Masahiro, Morise Masahiro, Hiltermann Jeroen, Mróz Robert, Ungureanu Andrei, Andrasina Igor, Chang Gee-Chen, Vynnychenko Ihor, Shparyk Yaroslav, Kryzhanivska Anna, Ross Helen, Mi Kailhong, Jamil Rodney, Williamson Michael, Spahr Joseph, Han Zhigang, Wang Mengzhao, Yang Zhixiong, Hu Jie, Li Wei, Zhao Jun, Feng Jifeng, Ma Shenglin, Zhou Xiangdong, Liang Zongan, Hu Yi, Chen Yuan, Bi Minghong, Shu Yongqian, Nan Kejun, Zhou Jianying, Zhang Wei, Ma Rui, Yang Nong, Lin Zhong, Wu Gang, Fang Jian, Zhang Helong, Wang Kai, Chen Zhendong
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 22, № 1, с. 51-65 DOI
• 
  • 2021 Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
  • Agapov M., Galliamov E., Kakotkin V., Kubyshkin V., Semina E., Garmanova T., Kazachenko E., Markaryan D.
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 22, № 11, с. 1507-1517 DOI
• • 2021 Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
  • Galle Peter R., Finn Richard S., Qin Shukui, Ikeda Masafumi, Zhu Andrew X., Kim Tae-You, Kudo Masatoshi, Breder Valeriy, Merle Philippe, Kaseb Ahmed, Li Daneng, Mulla Sohail, Verret Wendy, Xu Derek-Zhen, Hernandez Sairy, Ding Beiying, Liu Juan, Huang Chen, Lim Ho Yeong, Cheng Ann-Lii, Ducreux Michel
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 22, № 7, с. 991-1001 DOI
• • 2019 Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
  • Long Georgina V., Dummer Reinhard, Hamid Omid, Gajewski Thomas F., Caglevic Christian, Dalle Stephane, Arance Ana, Carlino Matteo S., Grob Jean-Jacques, Kim Tae Min, Demidov Lev, Robert Caroline, Larkin James, Anderson James R., Maleski Janet, Jones Mark, Diede Scott J., Mitchell Tara C.
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 20, № 8, с. 1083-1097 DOI
• • 2018 Adjuvant vemurafenib in resected, BRAF V600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
  • Maio Michele, Lewis Karl, Demidov Lev, Mandalà Mario, Bondarenko Igor, Ascierto Paolo A., Herbert Christopher, Mackiewicz Andrzej, Rutkowski Piotr, Guminski Alexander, Goodman Grant R., Simmons Brian, Ye Chenglin, Yan Yibing, Schadendorf Dirk, Cinat Gabriela, Fein Luis Enrique, Brown Michael, Guminski Alexander, Haydon Andrew, Khattak Adnan, McNeil Catriona, Parente Phillip, Power Jeremy, Roberts-Thomson Rachel, Sandhu Shahneen, Underhill Craig, Varma Suresh, Berger Thomas, Awada Ahmad, Blockx Nathalie, Buyse Veronique, Mebis Jeroen, Franke Fábio André, de Azevedo Sérgio Jobim, Lazaretti Nicolas Silva, Jamal Rahima, Mihalcioiu Catalin, Petrella Teresa, Savage Kerry, Song Xinni, Wong Ralph, Dabelic Nina, Plestina Stjepko, Vojnovic Zeljko, Arenberger Petr, Kocak Ivo, Krajsova Ivana, Kubala Eugen, Melichar Bohuslav, Vantuchova Yvetta, Putnik Kadri, Dreno Brigitte, Dutriaux Caroline, Grob Jean-Jacques, Joly Pascal, Lacour Jean-Philippe, Meyer Nicolas, Mortier Laurent, Thomas Luc, Fluck Michael, Gambichler Thilo, Hassel Jessica, Hauschild Axel, Schadendorf Dirk, Donnellan Paul, McCaffrey John, Power Derek, Ariad Samuel, Bar-Sela Gil, Hendler Daniel, Ron Ilan, Schachter Jacob, Ascierto Paolo, Berruti Alfredo, Bianchi Luca, Sileni Vanna Chiarion, Cognetti Francesco, Danielli Riccardo, Giacomo Anna Maria Di, Gianni Luca, Goldhirsch Aron, Guida Michele, Maio Michele, Mandalà Mario, Marchetti Paolo, Queirolo Paola, Santoro Armando, Kapiteijn Ellen, Mackiewicz Andrzej, Rutkowski Piotr, Ferreira Paula, Demidov Lev, Gafton Georgy, Makarova Yulia, Andric Zoran, Babovic Nada, Jovanovic Darjana, Sekulovic Lidija Kandolf, Cohen Graham, Dreosti Lydia, Vorobiof Daniel, Garcia Maria Teresa Curiel, Beveridge Roberto Diaz, Tarruella Margarita Majem, Rodas Ivan Marquez, Rodriguez Jose-M Puliats, Dominguez Antonio Rueda, Maroti Marianne, Papworth Karin, Michielin Olivier, Bondarenko Igor, Brown Ewan, Corrie Pippa, Harries Mark, Herbert Christopher, Kumar Satish, Martin-Clavijo Agustin, Middleton Mark, Patel Poulam, Talbot Toby, Agarwala Sanjiv, Chapman Paul, Conry Robert, Doolittle Gary, Gangadhar Tara, Hallmeyer Sigrun, Hamid Omid, Hernandez-Aya Leonel, Johnson Douglas, Kass Frederic, Kolevska Tatjana, Lewis Karl, Lunin Scott, Salama April, Sikic Branimir, Somer Bradley, Spigel David, Whitman Eric
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 19, № 4, с. 510-520 DOI
• • 2018 MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
  • Dreno Brigitte, Thompson John F., Smithers Bernard Mark, Santinami Mario, Jouary Thomas, Gutzmer Ralf, Levchenko Evgeny, Rutkowski Piotr, Grob Jean-Jacques, Korovin Sergii, Drucis Kamil, Grange Florent, Machet Laurent, Hersey Peter, Krajsova Ivana, Testori Alessandro, Conry Robert, Guillot Bernard, Kruit Wim H.J., Demidov Lev, Thompson John A., Bondarenko Igor, Jaroszek Jaroslaw, Puig Susana, Cinat Gabriela, Hauschild Axel, Goeman Jelle J., van Houwelingen Hans C., Ulloa-Montoya Fernando, Callegaro Andrea, Dizier Benjamin, Spiessens Bart, Debois Muriel, Brichard Vincent G., Louahed Jamila, Therasse Patrick, Debruyne Channa, Kirkwood John M.
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 19, № 7, с. 916-929 DOI
• 
  • 2018 Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort
  • Waszak Sebastian M., Northcott Paul A., Ivo Buchhalter, Robinson Giles W., Christian Sutter, Susanne Groebner, Grund Kerstin B., Laurence Brugières, Jones David T.W., Pajtler Kristian W., Sorana Morrissy A., Marcel Kool, Dominik Sturm, Lukas Chavez, Aurelie Ernst, Sebastian Brabetz, Michael Hain, Thomas Zichner, Maia Segura-Wang, Joachim Weischenfeldt, Tobias Rausch, Mardin Balca R., Xin Zhou, Cristina Baciu, Christian Lawerenz, Chan Jennifer A., Pascale Varlet, Lea Guerrini-Rousseau, Fults Daniel W., Wiesława Grajkowska, Peter Hauser, Nada Jabado, Young-Shin Ra, Karel Zitterbart, Shringarpure Suyash S., De La Vega Francisco M., Bustamante Carlos D., Ho-Keung Ng, Arie Perry, MacDonald Tobey J., Pablo Hernáiz Driever, Bendel Anne E., Bowers Daniel C., Geo rey McCowage, Chintagumpala Murali M., Richard Cohn, Timothy Hassall, Gudrun Fleischhack, Tone Eggen, Finn Wesenberg, Maria Feychting, Birgitta Lannering, Joachim Schüz, Johansen Christo er, Andersen Tina V., Martin Röösli, Kuehni Claudia E., Michael Grotzer, Kristina Kjaerheim, Monoranu Camelia M., Archer Tenley C., Elizabeth Duke, Pomeroy Scott L., Redmond Shelagh, Stephan Frank, David Sumerauer, Wolfram Scheurlen, Ryzhova Marina V., Till Milde, Kratz Christian P., David Samuel, Jinghui Zhang, Solomon David A., Marco Marra, Roland Eils, Bartram Claus R., von Ho Katja, Stefan Rutkowski, Vijay Ramaswamy, Gilbertson Richard J., Andrey Korshunov, Taylor Michael D., Peter Lichter, David Malkin, Amar Gajjar, Korbel Jan O., Pfister Stefan M.
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 19, № 6, с. 785-798 DOI
• • 2017 Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
  • Dummer Reinhard, Schadendorf Dirk, Ascierto Paolo A., Arance Ana, Dutriaux Caroline, Giacomo Anna Maria Di, Rutkowski Piotr, Vecchio Michele Del, Gutzmer Ralf, Mandala Mario, Thomas Luc, Demidov Lev, Garbe Claus, Hogg David, Liszkay Gabriella, Queirolo Paola, Wasserman Ernesto, Ford James, Weill Marine, Sirulnik L.Andres, Jehl Valentine, Bozón Viviana, Long Georgina V., Flaherty Keith
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 18, № 4, с. 435-445 DOI
• 
  • 2017 Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, phase 3 trial
  • Beer T.M., Hotte S.J., Saad F., Alekseev B., Matveev V., Fléchon A., Gravis G., Joly F., Chi K.N., Malik Z., Blumenstein B., Stewart P.S., Jacobs C.A., Fizazi K.
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 18, № 11, с. 1532-1542 DOI
• • 2016 Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
  • Ascierto PA, McArthur GA, Dréno B., Atkinson V., Liszkay G., Di Giacomo AM, Mandalà M., Demidov L., Stroyakovskiy D., Thomas L., de la Cruz-Merino L., Dutriaux C., Garbe C., Yan Y., Wongchenko M., Chang I., Hsu JJ, Koralek DO, Rooney I., Ribas A., Larkin J.
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), с. 1248-1260
• 
  • 2016 PREVENTABLE FRACTIONS OF CERVICAL CANCER VIA EFFECTIVE SCREENING IN SIX BALTIC, CENTRAL, AND EASTERN EUROPEAN COUNTRIES 2017–40: A POPULATION-BASED STUDY
  • Vaccarella S., Franceschi S., Plummer M., Bray F., Zaridze D., Poljak M., Veerus P.
  • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 17, № 10, с. 1445-1452